Sotera Health
About: Sotera Health Co provides sterilization, analytical lab testing, and advisory services to help ensure that medical, pharmaceutical and food products are safe for healthcare practitioners, patients, and consumers. The company operates in three segments: Sterigenics, Nordion, and Nelson Labs. Sterigenics provides outsourced terminal sterilization and irradiation services for medical device, pharmaceutical, food safety, and applications; Nordion provides Co-60 and gamma irradiators, which are the key components to the gamma sterilization process; and Nelson Labs provides outsourced microbiological and analytical chemistry testing for the medical device and pharmaceutical industries. Its geographical segments are the United States, Canada, Europe and other regions.
Employees: 3,000
0
Funds holding %
of 7,296 funds
0
Analysts bullish %
of 3 analysts
Fund manager confidence
Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)
16,060% more call options, than puts
Call options by funds: $808K | Put options by funds: $5K
1.78% more ownership
Funds ownership: 93.29% [Q4 2024] → 95.07% (+1.78%) [Q1 2025]
6% less funds holding
Funds holding: 216 [Q4 2024] → 204 (-12) [Q1 2025]
9% less funds holding in top 10
Funds holding in top 10: 11 [Q4 2024] → 10 (-1) [Q1 2025]
12% less repeat investments, than reductions
Existing positions increased: 65 | Existing positions reduced: 74
13% less capital invested
Capital invested by funds: $3.61B [Q4 2024] → $3.14B (-$471M) [Q1 2025]
25% less first-time investments, than exits
New positions opened: 27 | Existing positions closed: 36
Research analyst outlook
3 Wall Street Analysts provided 1 year price targets over the past 3 months
Low target
$12
5%
upside
Avg. target
$14
22%
upside
High target
$17
49%
upside
3 analyst ratings
2 positive
67%
1 neutral
33%
0 negative
0%
Goldman Sachs Matthew Sykes | 49%upside $17 | Buy Upgraded | 5 May 2025 |
Piper Sandler Jason Bednar | 14%upside $13 | Neutral Maintained | 23 Apr 2025 |
Barclays Luke Sergott | 5%upside $12 | Overweight Maintained | 10 Apr 2025 |
Financial journalist opinion
Neutral
Seeking Alpha
1 month ago
Sotera Health Company (SHC) Q1 2025 Earnings Call Transcript
Sotera Health Company (NASDAQ:SHC ) Q1 2025 Earnings Conference Call May 1, 2025 9:00 AM ET Company Participants Michael Petras - Chairman, Chief Executive Officer Jonathan Lyons - Chief Financial Officer Jason Peterson - Vice President of Investor Relations and Treasurer Conference Call Participants Patrick Donnelly - Citi Brett Fishbin - KeyBanc Matt Sykes - Goldman Sachs Luke Sergott - Barclays Dave Windley - Jefferies Jason Bednar - Piper Sandler Michael Polark - Wolfe Research Operator Good morning. And welcome to the Sotera Health First Quarter of 2025 Earnings Call.
Positive
Zacks Investment Research
1 month ago
Sotera Health (SHC) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
Although the revenue and EPS for Sotera Health (SHC) give a sense of how its business performed in the quarter ended March 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Positive
Zacks Investment Research
1 month ago
Sotera Health Company (SHC) Q1 Earnings and Revenues Top Estimates
Sotera Health Company (SHC) came out with quarterly earnings of $0.14 per share, beating the Zacks Consensus Estimate of $0.12 per share. This compares to earnings of $0.13 per share a year ago.
Neutral
GlobeNewsWire
1 month ago
Sotera Health Reports First-Quarter 2025 Results
CLEVELAND, May 01, 2025 (GLOBE NEWSWIRE) -- Sotera Health Company (“Sotera Health” or the “Company”) (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization solutions, lab testing and advisory services for the healthcare industry, today announced financial results for the three months ended March 31, 2025.
Neutral
GlobeNewsWire
1 month ago
Sotera Health Announces First-Quarter 2025 Earnings Release Date
CLEVELAND, April 17, 2025 (GLOBE NEWSWIRE) -- Sotera Health Company (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization solutions and lab testing and advisory services for the healthcare industry, today announced it will release its financial results for the first-quarter ended March 31, 2025 before the market opens on Thursday, May 1, 2025. Following the release, management will host a conference call at 9:00 a.m. Eastern Daylight Time to discuss the Company's financial results and operating highlights.
Neutral
Zacks Investment Research
2 months ago
Is the Options Market Predicting a Spike in Sotera Health (SHC) Stock?
Investors need to pay close attention to Sotera Health (SHC) stock based on the movements in the options market lately.
Positive
Seeking Alpha
2 months ago
Sotera Health Has A Great Deleveraging Path Ahead
Sotera Health offers essential sterilization, lab testing, and advisory services, ensuring safety and regulatory compliance for medical, pharmaceutical, and food products, with high customer retention and long-term contracts. The company operates through Sterigenics, Nordion, and Nelson Labs, with a global network and leading market positions in sterilization services and Co-60 supply. Despite a 6% revenue decline in FY24 due to Nordion's lumpy revenue, Sotera maintains high adjusted EBITDA margins (~50%) and plans for CapEx reduction and debt deleveraging.
Neutral
GlobeNewsWire
3 months ago
Nelson Labs Launches Innovative Rapid Sterility Testing to Significantly Expedite Product Sterility Results
Rapid Sterility Testing yields product sterility test results in as little as 6 days and can be used for broadscale medical device and pharmaceutical product application Rapid Sterility Testing yields product sterility test results in as little as 6 days and can be used for broadscale medical device and pharmaceutical product application
Neutral
Seeking Alpha
3 months ago
Sotera Health Company (SHC) Q4 2024 Earnings Call Transcript
Sotera Health Company (NASDAQ:SHC ) Q4 2024 Earnings Conference Call February 27, 2025 9:00 AM ET Company Participants Jason Peterson – Vice President of Investor Relations and Treasurer Michael Petras – Chairman and Chief Executive Officer Jon Lyons – Chief Financial Officer Conference Call Participants Patrick Donnelly - Citi Sean Dodge – RBC Capital Markets Luke Sergott – Barclays Casey Woodring – J.P. Morgan Brett Fishbin – KeyBanc Dave Windley – Jefferies Michael Polark – Wolfe Research Operator Good morning, and welcome to the Sotera Health Fourth Quarter and Full Year 2024 Conference Call.
Positive
Zacks Investment Research
3 months ago
Compared to Estimates, Sotera Health (SHC) Q4 Earnings: A Look at Key Metrics
Although the revenue and EPS for Sotera Health (SHC) give a sense of how its business performed in the quarter ended December 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Charts implemented using Lightweight Charts™